These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23347463)
1. Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. Banerjee I; Avatapalle B; Padidela R; Stevens A; Cosgrove KE; Clayton PE; Dunne MJ Clin Endocrinol (Oxf); 2013 Jun; 78(6):803-13. PubMed ID: 23347463 [TBL] [Abstract][Full Text] [Related]
2. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087 [TBL] [Abstract][Full Text] [Related]
3. The genetic basis of congenital hyperinsulinism. James C; Kapoor RR; Ismail D; Hussain K J Med Genet; 2009 May; 46(5):289-99. PubMed ID: 19254908 [TBL] [Abstract][Full Text] [Related]
4. The heterogeneity of focal forms of congenital hyperinsulinism. Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516 [TBL] [Abstract][Full Text] [Related]
5. [18F-fluoro-L-DOPA PET-CT imaging combined with genetic analysis for optimal classification and treatment in a child with severe congenital hyperinsulinism]. Arbizu Lostao J; Fernández-Marmiesse A; Garrastachu Zumarrán P; Martino Casado E; Azcona San Julián C; Carracedo A; Richter Echevarría JA An Pediatr (Barc); 2008 May; 68(5):481-5. PubMed ID: 18447993 [TBL] [Abstract][Full Text] [Related]
6. KATP channel mutations in congenital hyperinsulinism. Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999 [TBL] [Abstract][Full Text] [Related]
7. Congenital hyperinsulinism in Brazilian neonates: a study of histology, KATP channel genes, and proliferation of β cells. Lovisolo SM; Mendonça BB; Pinto EM; Manna TD; Saldiva PH; Zerbini MC Pediatr Dev Pathol; 2010; 13(5):375-84. PubMed ID: 20482375 [TBL] [Abstract][Full Text] [Related]
8. The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. Fékété CN; de Lonlay P; Jaubert F; Rahier J; Brunelle F; Saudubray JM J Pediatr Surg; 2004 Mar; 39(3):267-9. PubMed ID: 15017535 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of neonatal hyperinsulinism. Giurgea I; Bellanné-Chantelot C; Ribeiro M; Hubert L; Sempoux C; Robert JJ; Blankenstein O; Hussain K; Brunelle F; Nihoul-Fékété C; Rahier J; Jaubert F; de Lonlay P Horm Res; 2006; 66(6):289-96. PubMed ID: 17003566 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell. Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858 [TBL] [Abstract][Full Text] [Related]
11. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy. Powell PD; Bellanné-Chantelot C; Flanagan SE; Ellard S; Rooman R; Hussain K; Skae M; Clayton P; de Lonlay P; Dunne MJ; Cosgrove KE Diabetes; 2011 Apr; 60(4):1223-8. PubMed ID: 21411514 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism. Yorifuji T; Kawakita R; Hosokawa Y; Fujimaru R; Matsubara K; Aizu K; Suzuki S; Nagasaka H; Nishibori H; Masue M Clin Endocrinol (Oxf); 2013 Jun; 78(6):891-7. PubMed ID: 23067144 [TBL] [Abstract][Full Text] [Related]
13. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning. Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401 [TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinism in infancy--genetic aspects. Darendeliler F; Bas F Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():521-6. PubMed ID: 17551476 [TBL] [Abstract][Full Text] [Related]
16. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672 [TBL] [Abstract][Full Text] [Related]
17. [Congenital hyperinsulinism in newborn and infant]. Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094 [TBL] [Abstract][Full Text] [Related]
18. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism. Yorifuji T; Hosokawa Y; Fujimaru R; Kawakita R; Doi H; Matsumoto T; Nishibori H; Masue M Horm Res Paediatr; 2011; 76(4):286-90. PubMed ID: 21912073 [TBL] [Abstract][Full Text] [Related]